About us | About Scoope | Contact us
Scopelogo
 
google

 
  
 Sponsor Links
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NEWS ARCHIVE  
  News archives across months
  News archives across themes
  News archives across category
   
 
   
 

US 'Open for Whom? Equity in Open Knowledge' to be the theme of 2019 International Open Access Week - 06 Jun 2019

The 2019 Open Access Week Advisory Committee has announced that the theme for the 2019 International Open Access Week, to be held October 21-27, will be "Open for Whom? Equity in Open Knowledge".

As the transition to a system for sharing knowledge that is open by default accelerates, the question "open for whom?" is essential—both to consider and to act upon. Whose interests are being prioritized in the actions we take and in the platforms that we support? Whose voices are excluded? Are underrepresented groups included as full partners from the beginning? Are we supporting not only open access but also equitable participation in research communication? These questions will determine the extent to which emerging open systems for research will address inequities in the current system or replicate and reinforce them.

This year’s theme will build on the groundwork laid last year when discussions focused on "Designing Equitable Foundations for Open Knowledge." The 2018 theme highlighted the importance of making a central commitment to equity as we transition toward new systems for sharing knowledge, and the past twelve months have only seen the pace of that transition increase. Because of this, the Open Access Week Advisory Committee decided it was important to focus on equity again in 2019—to deepen conversations about being inclusive by design and to turn those conversations into action.

Established by SPARC and partners in the student community in 2008, International Open Access Week is an opportunity to take action in making openness the default for research—to raise the visibility of scholarship, accelerate research, and turn breakthroughs into better lives. This year’s Open Access Week will be held from October 21-27; however, those celebrating the week are encouraged to schedule local events whenever is most suitable during the year and to utilize themes that are most effective locally.

The global, distributed nature of Open Access Week will again play a particularly important role in this year’s theme. Strategies and structures for opening knowledge must be co-designed in and with the communities they serve—especially those that are often marginalized or excluded from these discussions altogether.

International Open Access Week is an important opportunity to catalyse new conversations, create connections across and between communities that can facilitate this co-design, and advance progress to build more equitable foundations for opening knowledge—discussion and action that must continue throughout the year, year in and year out. Diversity, equity, and inclusion must be prioritized year-round and integrated into the fabric of the open community, from how our infrastructure is built to how we organize community events.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.

Click here

Forward ThisForward This
More News in this Category

Conference proceedings/Debates/Workshops/Seminars

More News in this ThemeEvents and conferences
STORY TOOLS
Bookmark and Share
Share On LinkedIn Share On Facebook
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

US Elsevier’s Via Oncology wins 2019 MedTech Breakthrough Award for innovation in cancer care - 06 Jun 2019

MedTech Breakthrough, an independent organisation that recognises the top companies and solutions in the global health and medical technology market, has selected Elsevier’s Via Oncology as the winner of its ‘Best Computerized Decision Support Solution’ award in the 2019 MedTech Breakthrough Awards program.

Elsevier’s Via Oncology is a national leader in cancer care management and clinical decision support that incorporates advanced technology to identify and match eligible patients with clinical trial opportunities. Despite the rapidly growing rate of cancer worldwide, recruitment for clinical trials has become increasingly challenging, with fewer than 1 in 20 adults with cancer enrol in clinical trials.

Via Oncology aims to close this gap between cancer patients and clinical trial enrolment, as well as overall cancer care, by providing computerized decision support to increase enrolment rates and help ensure patients receive access to the most current and targeted therapies in development.

The MedTech Breakthrough Awards aim to honour excellence and recognise the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year’s program attracted more than 3,500 nominations from over 15 different countries throughout the world.

Elsevier announced in January 2018 that it had acquired Pittsburgh, Pennsylvania-based Via Oncology, a former subsidiary of UPMC (University of Pittsburgh Medical Center), one of the nation’s leading integrated healthcare delivery and financing systems.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.

Click here

Forward ThisForward This
More News in this Category

Awards, Certification and other Achievements

More News in this ThemeAwards, Certifications and other Achievements
STORY TOOLS
Bookmark and Share
Share On LinkedInShare On Facebook
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

UK The Cambridge Structural Database reaches one million structures - 06 Jun 2019

The Cambridge Crystallographic Data Centre (CCDC), experts in structural chemistry data, software and knowledge for materials and life science research and application, has announced a huge milestone for structural chemistry with the addition of the millionth structure into the Cambridge Structural Database (CSD).

The CSD is the world's repository of highly curated experimentally determined organic and metal-organic crystal structures. It is used globally by scientists in over 70 countries to understand how molecules behave and interact in three dimensions in the solid form and ultimately how this affects physical properties.

As the interest in ‘Big Data’ continues to grow in a time where machine learning and automation are changing the way pharmaceutical, agrochemical and many other industries work, reaching such a significant milestone is a huge achievement for the CCDC and the wider scientific community that contribute to and rely on this resource.

Large volumes of data such as this enable scientists to generate more replete answers from a more complete and diverse volume of information, ensuring confidence in the insights being drawn from the data. Furthermore, CCDC’s focus on ensuring the integrity of the data within the CSD through stringent quality assurance and control steps adds even more value and confidence that scientists are obtaining the highest quality information to inform their research.

This rich data resource, alongside advanced search, 3-D data mining, analysis and visualisation software from CCDC enables scientists from both industry and academia to further their research and predict new outcomes. In addition, knowledge derived from the CSD underpins computational chemistry and molecular modelling and is relied on by industry for the development and manufacturing of new drugs and within academia to teach chemistry.

CCDC have announced the 1,000,000th structure to be a N-heterocycle produced by a chalcogen bonding catalyst activating multiple reactions steps sequentially. In the paper the authors describe a class of extraordinary chalcogen-bonding catalysts which enable the assembly of discrete small molecules leading to the construction of N-heterocycles in a highly efficient manner. The structure was determined by Yao Wang and co-authors from Shandong University in China and published in the Journal of the American Chemical Society (JACS).

CCDC plans to further draw on insights and trends from the data to inform the direction of future research across different industries.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.

Click here

Forward ThisForward This
More News in this Category

Institute/Association/Council/Academy/ Society/Organisation

More News in this ThemeAwards, Certifications and other Achievements
STORY TOOLS
Bookmark and Share
Share On LinkedInShare On Facebook
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

US CSHL, Yale University, and BMJ set to launch new preprint server for the health sciences - 06 Jun 2019

Cold Spring Harbor Laboratory (CSHL), Yale University, and BMJ have announced the forthcoming launch of medRxiv (pronounced "med-archive"), a free online archive and distribution service for preprints in the medical and health sciences. medRxiv is expected to begin accepting manuscripts on June 6th and will be overseen by the three organisations.

Preprints are preliminary versions of research articles that researchers share with each other before they are published in a journal, to enhance dissemination of study methods and findings among the scientific community and to solicit feedback to help improve the final published article.

medRxiv’s founding organisations are Cold Spring Harbor Laboratory, creator of the biological preprint server bioRxiv (launched in 2013); BMJ, publisher of leading peer-reviewed journals and global healthcare knowledge provider; and Yale University, renowned clinical research and teaching institution.

medRxiv will host manuscripts from researchers around the world, regardless of their organisational affiliation, will be publisher-neutral, and will be guided in its mission by an international advisory board.

medRxiv will accept preprints of articles covering all aspects of research in the health sciences. A manuscript’s appearance in medRxiv does not imply endorsement of its methods, assumptions, conclusions, or scientific quality by BMJ, Yale, or CSHL. There will be prominent labels on all articles that designate them as pre-peer review content.

A manuscript may be posted prior to, or concurrently with, submission to a journal, but not if it has already been published. Most journals from a wide variety of publishers allow publication of journal articles that have appeared in early form on designated preprint servers.

Once posted on medRxiv, manuscripts have a digital object identifier (DOI), so are discoverable, indexable, and citable. They may be withdrawn if authors no longer stand by the findings or conclusions, but cannot routinely be removed.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.

Click here

Forward ThisForward This
More News in this Category

Reference Tools
Medical information - Healthcare

More News in this ThemeNew Release - Journals/Products/Services
STORY TOOLS
Bookmark and Share
Share On LinkedIn Share On Facebook
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections

US Akadémiai Kiadó partners with Sheridan PubFactory to host their journals - 06 Jun 2019

STM publisher Akadémiai Kiadó, majority owned by Wolters Kluwer, is relaunching their AKJournals publishing program - over 60 peer-reviewed STM titles - on Sheridan PubFactory’s online hosting platform.

Sheridan PubFactory can guide and support publishers through any point in the content lifecycle. The PubFactory platform and publishing services have been adopted by prestigious publishers like OUP, Journal of Neurosurgery Publishing Group, American Society for Horticultural Science, and the Society for Endocrinology’s Bioscientifica Ltd. Today, the PubFactory platform is host to over 2,300 journals, more than 400,000 books, numerous databases, and reference works.

Akadémiai Kiadó was founded in 1828 by the Hungarian Academy of Sciences and is now majority owned by Wolters Kluwer. It is Hungary’s oldest continuously operating publishing house and one of the largest scientific publishers in Central and Eastern Europe. Its portfolio includes international peer-reviewed journals, conference series and online scientific content services. Akadémiai Kiadó claims to publish the largest portfolio of scientific, technical and medical journals in Hungary with more than 60 peer-reviewed journals.

Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.

Click here

Forward ThisForward This
More News in this Category

Reference Tools

More News in this ThemeAlliances, Partnerships & Consolidations
STORY TOOLS
Bookmark and Share
Share On LinkedIn Share On Facebook
Tweet This !DeliciousBookmark this
Digg ThisLinkedIn Connections
 
For banner ads click here